Evidence map›Paper›PMID 32864638›Full record

ArticleHeart rhythm O22020

Inhibition of voltage-gated Na

Rachel E Caves, Alexander Carpenter, Stéphanie C Choisy, Ben Clennell, Hongwei Cheng, Cameron McNiff, Brendan Mann, James T Milnes, Jules C Hancox, Andrew F James

Open access · goldAbstract read
In one paragraph

Article in Heart rhythm O2, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Biophysical properties of NaScientific reports · 2023
    Article
  6. The Antidepressant Paroxetine Reduces the Cardiac Sodium Current.International journal of molecular sciences · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Rachel E CavesSchool of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, United Kingdom.
Alexander CarpenterSchool of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, United Kingdom.
Stéphanie C ChoisySchool of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, United Kingdom.
Ben ClennellSchool of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, United Kingdom.
Hongwei ChengSchool of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, United Kingdom.
Cameron McNiffSchool of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, United Kingdom.
Brendan MannSchool of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, United Kingdom.
James T MilnesXention Ltd, Cambridge, United Kingdom.
Jules C HancoxSchool of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, United Kingdom.
Andrew F JamesSchool of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, United Kingdom.
University of Bristol · GBXention (United Kingdom) · GB

Funding

British Heart Foundation PG/15/55/31568Medical Research Council MR/S021299/1
6 · The paper itself

Abstract

backgroundAtrial-ventricular differences in voltage-gated Na

objectiveThe present study investigated atrial-ventricular differences in the biophysical properties and inhibition by eleclazine of voltage-gated Na

methodsThe fast and late components of whole-cell voltage-gated Na

resultsAtrial

conclusionsDifferences exist between rat atrial and ventricular myocytes in the biophysical properties of

Indexed as

Antiarrhythmic drugAtrial myocytesCardiac regional heterogeneityINaINa,LateNa+ channel blockerVentricular myocytes

Identifiers

PMID32864638
PMCPMC7442036
OpenAlexW3027959444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.